Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Fishing Caddy inventor pours family business into new product: Anywhere Cup Holder
Joe Pippins’ latest invention — the Anywhere Cup Holder — can support as much as 50 pounds in a single cup, he said. It’s a solution that serves the needs of everyone from mechanics and fishing enthusiasts to gardeners and people who entertain in their homes, said Pippins, founder of Live Holdings, which produces the…
Selling ‘the infinite commodity’: Farmobile leverages blockchain to build secure data store
With more than a million acres of field data amassed by Farmobile, farmers now need an exchange to securely connect them with buyers of the digital machine and agronomic information they’ve harvested, said Jason Tatge. A newly opened Farmobile DataStore, which leverages elements of blockchain technology fueled by Intel Sawtooth and Amazon Web Services to…
Rif Raf Giraffe plays matchmaker for buildings, money and artists in Crossroads
Jason Harrington sees opportunity in places often overlooked – alleys, elevator shafts and the sides of brick buildings. For the artist better known as Rif Raf Giraffe, they’re vast canvasses, waiting to be filled with gallons and gallons of paint and passion. Harrington recently traversed the East Crossroads Arts District in search of more real…
Black & Veatch delivers first consumer product ever: Solarhood
After more than 100 years in business, engineering giant Black & Veatch has launched its first consumer product: Solarhood. Built through the B&V Growth Accelerator program, the company created Solarhood to streamline the process for homeowners to tap solar power. The Solarhood mobile and web-based app allow homeowners to access the feasibility of going solar,…